In the BioHarmony Drug Report Database
Dofetilide
Tikosyn (dofetilide) is a small molecule pharmaceutical. Dofetilide was first approved as Tikosyn on 1999-10-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. The pharmaceutical is active against potassium voltage-gated channel subfamily H member 2. In addition, it is known to target potassium voltage-gated channel subfamily H member 1.
Trade Name
|
Tikosyn |
|---|---|
Common Name
|
dofetilide |
ChEMBL ID
|
CHEMBL473 |
Indication
|
atrial fibrillation, atrial flutter, cardiac arrhythmias |
Drug Class
|
Class III antiarrhythmic agents |
Image (chem structure or protein)